On October 10, 2019 Lipocine Inc. (NASDAQ: LPCN), clinical-stage biopharmaceutical company, reported that Dr. Mahesh Patel, Chairman, President and CEO, will provide a corporate overview at the H.C. Wainwright 3rd Annual NASH Investor Conference, being held October 21, 2019 at the St. Regis Hotel in New York City (Press release, Lipocine, OCT 10, 2019, View Source [SID1234540939]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation Details:
Date:
Monday, October 21
Time:
2:40pm Eastern Time
Location:
St. Regis Hotel, New York, New York
Webcast: